Literature DB >> 18612505

Corrected QT interval prolongation after an overdose of escitalopram, morphine, oxycodone, zopiclone and benzodiazepines.

Adrian Baranchuk1, Christopher S Simpson, Michelle Methot, Kara Gibson, David Strum.   

Abstract

Escitalopram is the recently marketed S-enantiomer of the widely used antidepressant citalopram. Data from intentional overexposure to this medication are limited. Twelve-lead electrocardiogram (ECG) effects from racemic citalopram have been described; however, the present report is the first, to the best of the authors' knowledge, that describes all the reported abnormalities in a single patient receiving escitalopram. A 52-year-old man with a history of depression treated with escitalopram 10 mg/day, extended-release morphine 30 mg/day and zopiclone 15 mg/day was found unconscious at his home. He was known to have attempted suicide three weeks previously. Partially emptied bottles of escitalopram, morphine, oxycodone, zopiclone, lorazepam and diazepam were found close to the patient. He was transferred to the emergency department, where airway management and other supportive care were initiated. The patient was transferred to the intensive care unit. The initial 12-lead ECG demonstrated junctional rhythm at 48 beats/min, a wide complex escape (145 ms) with right bundle branch morphology and a prolonged corrected QT interval at 650 ms. Cardiac monitoring was undertaken. No ventricular arrhythmias or torsade de pointes were detected. No specific treatment for shortening the QT was implemented. Another 12-lead ECG performed 48 h later demonstrated sinus tachycardia with a normal corrected QT, normal PR interval and normal QRS duration. The effects of the overdose of escitalopram on the ECG and its interactions with other drugs are reviewed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18612505      PMCID: PMC2649624          DOI: 10.1016/s0828-282x(08)70643-3

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  11 in total

1.  Inhibitory actions of the selective serotonin re-uptake inhibitor citalopram on HERG and ventricular L-type calcium currents.

Authors:  Harry J Witchel; Vijay K Pabbathi; Giovanna Hofmann; Ashok A Paul; Jules C Hancox
Journal:  FEBS Lett       Date:  2002-02-13       Impact factor: 4.124

2.  Escitalopram intoxication.

Authors:  Fatih Volkan Yuksel; Verda Tuzer; Erol Goka
Journal:  Eur Psychiatry       Date:  2005-01       Impact factor: 5.361

3.  [Citalopram is not safe from the cardiac point of view--SSRI preparations can cause prolonged QTc time].

Authors:  Ingegerd Odar-Cederlöf; Peter Hjelmström; Ingela Jersenius; Marine Andersson; Gundars Rasmanis; Ulf Bergman
Journal:  Lakartidningen       Date:  2006 Apr 5-11

4.  Application of pharmacokinetic-pharmacodynamic modelling in management of QT abnormalities after citalopram overdose.

Authors:  Geoffrey K Isbister; Lena E Friberg; Stephen B Duffull
Journal:  Intensive Care Med       Date:  2006-05-10       Impact factor: 17.440

5.  Outcomes after supratherapeutic escitalopram ingestions.

Authors:  Frank LoVecchio; David Watts; Joseph Winchell; Jason Knight; Tim McDowell
Journal:  J Emerg Med       Date:  2006-01       Impact factor: 1.484

6.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

7.  QTc interval prolongation associated with citalopram overdose: a case report and literature review.

Authors:  G Catalano; M C Catalano; M A Epstein; P E Tsambiras
Journal:  Clin Neuropharmacol       Date:  2001 May-Jun       Impact factor: 1.592

Review 8.  Psychotropic drugs and the ECG: focus on the QTc interval.

Authors:  Paul J Goodnick; Jason Jerry; Francisco Parra
Journal:  Expert Opin Pharmacother       Date:  2002-05       Impact factor: 3.889

Review 9.  Escitalopram: a review of its use in the management of major depressive disorder.

Authors:  David Murdoch; Susan J Keam
Journal:  Drugs       Date:  2005       Impact factor: 9.546

10.  [Citalopram and Torsades de Pointes. A case report].

Authors:  C Meuleman; P Jourdain; M Bellorini; N Sadeg; J Loiret; N Guillard; B Thebault; F Funck
Journal:  Arch Mal Coeur Vaiss       Date:  2001-09
View more
  10 in total

1.  QT interval prolongation and Torsades de Pointes with donepezil, rivastigmine and galantamine.

Authors:  Katie Malone; Jules C Hancox
Journal:  Ther Adv Drug Saf       Date:  2020-08-17

2.  Escitalopram block of hERG potassium channels.

Authors:  Yun Ju Chae; Ji Hyun Jeon; Hong Joon Lee; In-Beom Kim; Jin-Sung Choi; Ki-Wug Sung; Sang June Hahn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-09-18       Impact factor: 3.000

Review 3.  Opioids and Cardiac Arrhythmia: A Literature Review.

Authors:  Mina Behzadi; Siyavash Joukar; Ahmad Beik
Journal:  Med Princ Pract       Date:  2018-08-02       Impact factor: 1.927

Review 4.  Quetiapine, QTc interval prolongation, and torsade de pointes: a review of case reports.

Authors:  Mehrul Hasnain; W Victor R Vieweg; Robert H Howland; Christopher Kogut; Ericka L Breden Crouse; Jayanthi N Koneru; Jules C Hancox; Geneviève C Digby; Adrian Baranchuk; Anand Deshmukh; Ananda K Pandurangi
Journal:  Ther Adv Psychopharmacol       Date:  2014-06

Review 5.  QTc interval prolongation and torsade de pointes associated with second-generation antipsychotics and antidepressants: a comprehensive review.

Authors:  Mehrul Hasnain; W Victor R Vieweg
Journal:  CNS Drugs       Date:  2014-10       Impact factor: 5.749

6.  Clinical use of antidepressant therapy and associated cardiovascular risk.

Authors:  W Stephen Waring
Journal:  Drug Healthc Patient Saf       Date:  2012-08-17

7.  Failure to Treat Torsades de Pointes.

Authors:  Payam Yazdan-Ashoori; Genevieve Digby; Adrian Baranchuk
Journal:  Cardiol Res       Date:  2012-01-20

8.  Prediction of Ventricular Arrhythmias by QRS/QTc - Ratio in Citalopram or Escitalopram Intoxication.

Authors:  Erik Sveberg Dietrichs; Godfrey L Smith
Journal:  Front Med (Lausanne)       Date:  2022-03-16

9.  Drug-Induced QT Prolongation as a Result of an Escitalopram Overdose in a Patient with Previously Undiagnosed Congenital Long QT Syndrome.

Authors:  Paul Singh; J Martin Maldonado-Duran
Journal:  Case Rep Med       Date:  2014-07-01

Review 10.  The Impact of Opioids on Cardiac Electrophysiology.

Authors:  Erich F Wedam; Mark C Haigney
Journal:  Curr Cardiol Rev       Date:  2016
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.